Physician profile
Mark Awad
NPI 1881272011
$4,623.83
in general payments reported to CMS, 2019-2025
9 companies · $2,380 in 2025
The $2,380 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $130 · 2023: $292 · 2024: $1,822 · 2025: $2,380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,747 · Education: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,747.29 |
| Education | $746.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,595.49 | 2024-2025 | Endurant Iis, Valiant Captivia, Hawkone |
| Penumbra, INC. | $1,316.19 | 2025 | Indigo System, Ruby Coil |
| Silk Road Medical, INC. | $734.45 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Bolton Medical INC | $394.58 | 2023-2024 | Treo Abdominal Stent-Graft System |
| Stryker Corporation | $237.38 | 2025 | Artix Mt, 1788 |
| Shockwave Medical, INC | $145.54 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $130.30 | 2022 | |
| Terumo Medical Corporation | $44.31 | 2024 | Azur Cx Detachable |
| Angiodynamics, INC. | $25.59 | 2023 | Angiovac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Awad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.